Personal tools

MCL coexpression mm9:1857: Difference between revisions

From FANTOM5_SSTAR

Jump to: navigation, search
No edit summary
No edit summary
Line 6: Line 6:
|ontology_enrichment_disease=
|ontology_enrichment_disease=
|ontology_enrichment_uberon=UBERON:0001017!1.86e-28!73;UBERON:0001016!3.43e-27!75;UBERON:0000073!5.65e-25!54;UBERON:0001049!2.39e-23!52;UBERON:0005068!2.39e-23!52;UBERON:0006241!2.39e-23!52;UBERON:0007135!2.39e-23!52;UBERON:0000955!1.05e-19!47;UBERON:0006238!1.05e-19!47;UBERON:0003080!1.22e-19!40;UBERON:0002616!3.17e-19!46;UBERON:0004121!4.50e-19!95;UBERON:0000924!4.50e-19!95;UBERON:0006601!4.50e-19!95;UBERON:0002020!7.18e-19!34;UBERON:0002780!8.55e-19!39;UBERON:0001890!8.55e-19!39;UBERON:0006240!8.55e-19!39;UBERON:0002346!5.25e-18!64;UBERON:0003075!5.25e-18!64;UBERON:0007284!5.25e-18!64;UBERON:0010371!5.32e-16!73;UBERON:0003528!2.32e-15!29;UBERON:0002791!2.32e-15!29;UBERON:0001893!2.32e-15!29;UBERON:0003056!8.68e-15!49;UBERON:0010314!7.71e-10!92;UBERON:0000956!1.03e-08!21;UBERON:0001869!1.03e-08!21;UBERON:0000203!1.03e-08!21;UBERON:0002420!1.25e-08!8;UBERON:0007245!1.25e-08!8;UBERON:0010009!1.25e-08!8;UBERON:0010011!1.25e-08!8;UBERON:0000454!1.25e-08!8
|ontology_enrichment_uberon=UBERON:0001017!1.86e-28!73;UBERON:0001016!3.43e-27!75;UBERON:0000073!5.65e-25!54;UBERON:0001049!2.39e-23!52;UBERON:0005068!2.39e-23!52;UBERON:0006241!2.39e-23!52;UBERON:0007135!2.39e-23!52;UBERON:0000955!1.05e-19!47;UBERON:0006238!1.05e-19!47;UBERON:0003080!1.22e-19!40;UBERON:0002616!3.17e-19!46;UBERON:0004121!4.50e-19!95;UBERON:0000924!4.50e-19!95;UBERON:0006601!4.50e-19!95;UBERON:0002020!7.18e-19!34;UBERON:0002780!8.55e-19!39;UBERON:0001890!8.55e-19!39;UBERON:0006240!8.55e-19!39;UBERON:0002346!5.25e-18!64;UBERON:0003075!5.25e-18!64;UBERON:0007284!5.25e-18!64;UBERON:0010371!5.32e-16!73;UBERON:0003528!2.32e-15!29;UBERON:0002791!2.32e-15!29;UBERON:0001893!2.32e-15!29;UBERON:0003056!8.68e-15!49;UBERON:0010314!7.71e-10!92;UBERON:0000956!1.03e-08!21;UBERON:0001869!1.03e-08!21;UBERON:0000203!1.03e-08!21;UBERON:0002420!1.25e-08!8;UBERON:0007245!1.25e-08!8;UBERON:0010009!1.25e-08!8;UBERON:0010011!1.25e-08!8;UBERON:0000454!1.25e-08!8
|tfbs_overrepresentation_for_novel_motifs=0.557864,0.612204,0.529553,0.603273,0.406364,0.618805,0.715644,0.812379,0.310789,0.115752,0.668936,0.702872,1.47559,0.728641,0.424775,0,2.14511,0.397593,0.283802,0.545768,0.489529,0.44579,0.727684,0.404661,0.537749,0.757752,0.274609,0.641282,1.15581,0.227599,0.626183,1.03545,0.395107,0.253145,0.425309,0.0566307,0.384813,0.699032,0.947152,0.328675,0.401916,0.631725,0.134724,0.426986,0.227872,1.44282,0.847828,0.658142,0.115788,0.459555,0.912738,0.786094,1.17664,1.18062,1.19842,0.73621,1.18377,0.689304,0.26467,0.734051,1.01481,0.796017,0.323911,0.901018,0.747985,0.943088,1.33705,1.68977,1.00999,1.54147,0.509047,0.30684,7.13762,1.23259,0.257421,0.245132,0.253065,0.835925,0.997094,0.494135,0.308173,0.948899,0.794502,0.293164,1.1148,0.0793594,0.297068,0.227755,0.852952,1.85284,1.40768,1.11989,1.04863,0.412897,4.48918,0.3366,0.297538,1.05152,0.848095,0.590368,0.384901,1.03517,2.61649,0.913356,0.91226,0.631253,0.97421,0.653843,0.499439,2.13274,0.550229,1.16464,0.495367,0.674448,1.41481,0.399936,0.0998646,0.607321,0.932233,0.380707,1.23809,0.879184,0.759676,0.834976,1.46955,1.00091,0.724289,1.04166,1.33551,0.416189,1.14546,0.595426,1.3055,0.750642,1.43666,0.867604,0.566955,0.633235,1.3869,2.2222,1.82084,1.34183,0.772375,1.04623,0.905521,0.632211,0.851091,2.18247,0.569503,0.408309,0.230371,3.34092,1.18223,0.343194,0.749664,1.26545,0.787153,0.438007,0.555203,1.39093,1.39653,2.51743,1.00137,0.547782,0.90208,0.741834,0.383572,0.701187,3.33644
}}
}}

Revision as of 20:32, 26 November 2012


Phase1 CAGE Peaks

 Short description
Mm9::chrX:108008153..108008162,-p@chrX:108008153..108008162
-
Mm9::chrX:108009602..108009615,+p4@Pou3f4
Mm9::chrX:108009734..108009752,+p2@Pou3f4
Mm9::chrX:108009761..108009788,+p1@Pou3f4
Mm9::chrX:108011021..108011031,+p@chrX:108011021..108011031
+


Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data


no results for this coexpression

Relative expression of the co-expression cluster over median <br>Analyst:





Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br><br>


Uber Anatomy
Ontology termp-valuen
central nervous system1.86e-2873
nervous system3.43e-2775
regional part of nervous system5.65e-2554
neural tube2.39e-2352
neural rod2.39e-2352
future spinal cord2.39e-2352
neural keel2.39e-2352
brain1.05e-1947
future brain1.05e-1947
anterior neural tube1.22e-1940
regional part of brain3.17e-1946
ectoderm-derived structure4.50e-1995
ectoderm4.50e-1995
presumptive ectoderm4.50e-1995
gray matter7.18e-1934
regional part of forebrain8.55e-1939
forebrain8.55e-1939
future forebrain8.55e-1939
neurectoderm5.25e-1864
neural plate5.25e-1864
presumptive neural plate5.25e-1864
ecto-epithelium5.32e-1673
brain grey matter2.32e-1529
regional part of telencephalon2.32e-1529
telencephalon2.32e-1529
pre-chordal neural plate8.68e-1549
structure with developmental contribution from neural crest7.71e-1092
cerebral cortex1.03e-0821
cerebral hemisphere1.03e-0821
pallium1.03e-0821
basal ganglion1.25e-088
nuclear complex of neuraxis1.25e-088
aggregate regional part of brain1.25e-088
collection of basal ganglia1.25e-088
cerebral subcortex1.25e-088


TFBS overrepresentation<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data


Novel motifs




JASPAR motifs


Motifs-log10(p-value)

{{{tfbs_overrepresentation_jaspar}}}